• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

十五种含有机阴离子的4-(2-甲氧基苯基)哌嗪-1-鎓盐:零维、一维、二维和三维的超分子组装

Fifteen 4-(2-meth-oxy-phen-yl)piperazin-1-ium salts containing organic anions: supra-molecular assembly in zero, one, two and three dimensions.

作者信息

Harish Chinthal Chayanna, Kavitha Channappa N, Yathirajan Hemmige S, Foro Sabine, Rathore Ravindranath S, Glidewell Christopher

机构信息

Department of Studies in Chemistry, University of Mysore, Manasagangotri, Mysuru-570 006, India.

Department of Chemistry, Maharani's Science College for Women, Mysuru-570 001, India.

出版信息

Acta Crystallogr E Crystallogr Commun. 2020 Oct 30;76(Pt 11):1779-1793. doi: 10.1107/S2056989020014097. eCollection 2020 Nov 1.

DOI:10.1107/S2056989020014097
PMID:33209353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7643239/
Abstract

Fifteen 4-(2-meth-oxy-phen-yl)piperazin-1-ium salts containing organic anions have been prepared and structurally characterized. In the isostructural 4-chloro-benzoate and 4-bromo-benzoate salts, CHNO·CHClO (I) and CHNO·CHBrO (II), and the 4-iodo-benzoate salt CHNO·CHIO (III), the ions are linked by N-H⋯O hydrogen bonds, forming centrosymmetric (12) four-ion aggregates; a similar aggregate is formed in the 2-chloro-benzoate salt (V), isomeric with (I). In the 2-fluoro-benzoate salt CHNO·CHFO (IV), and the isomorphous pair of salts, the 2-bromo-benzoate (VI), isomeric with (II) and 2-iodo-benzoate (VII), isomeric with (III), N-H⋯O and C-H⋯π(arene) interactions link the components into three-dimensional arrays. Four-ion (12) aggregates are also found in the 2-methyl-benzoate, 4-amino-benzoate and 4-nitro-benzoate salts, CHNO·CHO (VIII), CHNO·CHNO (IX) and CHNO·CHNO (X), but those in (IX) are linked into complex sheets by an additional N-H⋯O hydrogen bond. In the 3,5-dinitrobenzoate salt, CHNO·CHNO ·2HO (XI), N-H⋯O and O-H⋯O hydrogen bonds link the components into a complex ribbon structure. In the picrate salt, CHNO·CHNO (XII), the four-ion aggregates are linked into chains of rings by C-H⋯O hydrogen bonds. In the hydrogen maleate salt, CHNO·CHO (XIII), two- and three-centre hydrogen bonds link the ions into a ribbon structure while both anions contain very short but asymmetric O-H⋯O hydrogen bonds, having O⋯O distances of 2.4447 (16) and 2.4707 (17) Å. O-H⋯O Hydrogen bonds link the anions in the hydrogen fumarate salt (XIV), isomeric with (XIII), into chains that are linked into sheets N-H⋯O hydrogen bonds. In the hydrogen (2,3)-tartrate salt, CHNO·CHO ·1.698HO (XV), the anions are linked into sheets by O-H⋯O hydrogen bonds. Comparisons are made with the structures of some related compounds.

摘要

已制备并对15种含有机阴离子的4-(2-甲氧基苯基)哌嗪-1-鎓盐进行了结构表征。在同构的4-氯苯甲酸盐和4-溴苯甲酸盐CHNO·CHClO (I)和CHNO·CHBrO (II)以及4-碘苯甲酸盐CHNO·CHIO (III)中,离子通过N-H⋯O氢键相连,形成中心对称的(12)四离子聚集体;在与(I)异构的2-氯苯甲酸盐(V)中形成了类似的聚集体。在2-氟苯甲酸盐CHNO·CHFO (IV)以及同构盐对、与(II)异构的2-溴苯甲酸盐(VI)和与(III)异构的2-碘苯甲酸盐(VII)中,N-H⋯O和C-H⋯π(芳烃)相互作用将各组分连接成三维阵列。在2-甲基苯甲酸盐、4-氨基苯甲酸盐和4-硝基苯甲酸盐CHNO·CHO (VIII)、CHNO·CHNO (IX)和CHNO·CHNO (X)中也发现了四离子(12)聚集体,但(IX)中的聚集体通过额外的N-H⋯O氢键连接成复杂的片层。在3,5-二硝基苯甲酸盐CHNO·CHNO ·2HO (XI)中,N-H⋯O和O-H⋯O氢键将各组分连接成复杂的带状结构。在苦味酸盐CHNO·CHNO (XII)中,四离子聚集体通过C-H⋯O氢键连接成环链。在马来酸氢盐CHNO·CHO (XIII)中,双中心和三中心氢键将离子连接成带状结构,而两个阴离子都含有非常短但不对称的O-H⋯O氢键,O⋯O距离分别为2.4447 (16)和2.4707 (17) Å。O-H⋯O氢键将与(XIII)异构的富马酸氢盐(XIV)中的阴离子连接成链,这些链通过N-H⋯O氢键连接成片层。在(2,3)-酒石酸氢盐CHNO·CHO ·1.698HO (XV)中,阴离子通过O-H⋯O氢键连接成片层。并与一些相关化合物的结构进行了比较。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/aaa01ee998b9/e-76-01779-fig29.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/13c031fc2d12/e-76-01779-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/c912ce753409/e-76-01779-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/b9969bd9365e/e-76-01779-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/8fb5857dde07/e-76-01779-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/117e758a4263/e-76-01779-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/194a0d85a857/e-76-01779-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/2c45df359a7e/e-76-01779-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/8a879a8f2c49/e-76-01779-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/521475618cf6/e-76-01779-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/531c304890b0/e-76-01779-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/756923dbb6db/e-76-01779-fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/34914fc56c28/e-76-01779-fig12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/a0db92a944cd/e-76-01779-fig13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/a66fdddccac0/e-76-01779-fig14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/bf55c5c72554/e-76-01779-fig15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/1470da72aa68/e-76-01779-fig16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/27f16d257133/e-76-01779-fig17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/29867827986b/e-76-01779-fig18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/2d1dd2986ce0/e-76-01779-fig19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/51b6fce20ec5/e-76-01779-fig20.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/42e2cb19a115/e-76-01779-fig21.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/4e288d6d264c/e-76-01779-fig22.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/ea812aba30cf/e-76-01779-fig23.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/0cab01cd4ec0/e-76-01779-fig24.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/78a2e058ae58/e-76-01779-fig25.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/5c98c1f0d78d/e-76-01779-fig26.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/603a08767982/e-76-01779-fig27.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/12b1693d3451/e-76-01779-fig28.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/aaa01ee998b9/e-76-01779-fig29.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/13c031fc2d12/e-76-01779-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/c912ce753409/e-76-01779-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/b9969bd9365e/e-76-01779-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/8fb5857dde07/e-76-01779-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/117e758a4263/e-76-01779-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/194a0d85a857/e-76-01779-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/2c45df359a7e/e-76-01779-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/8a879a8f2c49/e-76-01779-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/521475618cf6/e-76-01779-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/531c304890b0/e-76-01779-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/756923dbb6db/e-76-01779-fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/34914fc56c28/e-76-01779-fig12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/a0db92a944cd/e-76-01779-fig13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/a66fdddccac0/e-76-01779-fig14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/bf55c5c72554/e-76-01779-fig15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/1470da72aa68/e-76-01779-fig16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/27f16d257133/e-76-01779-fig17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/29867827986b/e-76-01779-fig18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/2d1dd2986ce0/e-76-01779-fig19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/51b6fce20ec5/e-76-01779-fig20.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/42e2cb19a115/e-76-01779-fig21.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/4e288d6d264c/e-76-01779-fig22.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/ea812aba30cf/e-76-01779-fig23.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/0cab01cd4ec0/e-76-01779-fig24.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/78a2e058ae58/e-76-01779-fig25.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/5c98c1f0d78d/e-76-01779-fig26.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/603a08767982/e-76-01779-fig27.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/12b1693d3451/e-76-01779-fig28.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b3/7643239/aaa01ee998b9/e-76-01779-fig29.jpg

相似文献

1
Fifteen 4-(2-meth-oxy-phen-yl)piperazin-1-ium salts containing organic anions: supra-molecular assembly in zero, one, two and three dimensions.十五种含有机阴离子的4-(2-甲氧基苯基)哌嗪-1-鎓盐:零维、一维、二维和三维的超分子组装
Acta Crystallogr E Crystallogr Commun. 2020 Oct 30;76(Pt 11):1779-1793. doi: 10.1107/S2056989020014097. eCollection 2020 Nov 1.
2
Twelve 4-(4-meth-oxy-phen-yl)piperazin-1-ium salts containing organic anions: supra-molecular assembly in one, two and three dimensions.十二种含有机阴离子的4-(4-甲氧基苯基)哌嗪-1-鎓盐:一维、二维和三维超分子组装
Acta Crystallogr E Crystallogr Commun. 2019 Sep 20;75(Pt 10):1494-1506. doi: 10.1107/S2056989019012702. eCollection 2019 Oct 1.
3
The crystal structures of salts of -(4-fluoro-phen-yl)piperazine with four aromatic carb-oxy-lic acids and with picric acid.-(4-氟苯基)哌嗪与四种芳香羧酸及苦味酸形成的盐的晶体结构
Acta Crystallogr E Crystallogr Commun. 2020 Jul 3;76(Pt 8):1179-1186. doi: 10.1107/S2056989020008749. eCollection 2020 Aug 1.
4
Three 4-(4-fluoro-phen-yl)piperazin-1-ium salts containing organic anions: supra-molecular assembly in one, two and three dimensions.三种含有有机阴离子的4-(4-氟苯基)哌嗪-1-鎓盐:一维、二维和三维超分子组装体
Acta Crystallogr E Crystallogr Commun. 2020 May 15;76(Pt 6):841-847. doi: 10.1107/S2056989020006398. eCollection 2020 Jun 1.
5
Crystal structures of the recreational drug -(4-meth-oxy-phen-yl)piperazine (MeOPP) and three of its salts.消遣性药物1-(4-甲氧基苯基)哌嗪(MeOPP)及其三种盐的晶体结构。
Acta Crystallogr E Crystallogr Commun. 2020 Mar 5;76(Pt 4):488-495. doi: 10.1107/S2056989020002844. eCollection 2020 Apr 1.
6
Syntheses and crystal structures of four 4-(4-meth-oxy-phen-yl)piperazin-1-ium salts: tri-fluoro-acetate, 2,3,4,5,6-penta-fluoro-benzoate, 4-iodo-benzoate, and a polymorph with 4-methyl-benzoate.四种4-(4-甲氧基苯基)哌嗪-1-鎓盐的合成与晶体结构:三氟乙酸盐、2,3,4,5,6-五氟苯甲酸盐、4-碘苯甲酸盐以及4-甲基苯甲酸盐的一种多晶型物
Acta Crystallogr E Crystallogr Commun. 2023 Mar 23;79(Pt 4):380-385. doi: 10.1107/S2056989023002529. eCollection 2023 Mar 1.
7
The structures of eleven (4-phen-yl)piperazinium salts containing organic anions.十一种含有机阴离子的(4-苯基)哌嗪鎓盐的结构
Acta Crystallogr E Crystallogr Commun. 2022 Sep 22;78(Pt 10):1016-1027. doi: 10.1107/S2056989022009057. eCollection 2022 Oct 1.
8
Syntheses and crystal structures of 4-(4-meth-oxy-phen-yl)piperazin-1-ium 4-methyl-benzoate monohydrate and bis-[4-(4-meth-oxy-phen-yl)piperazin-1-ium] benzene-1,2-di-carboxyl-ate.4-(4-甲氧基苯基)哌嗪-1-鎓 4-甲基苯甲酸盐一水合物和双-[4-(4-甲氧基苯基)哌嗪-1-鎓]苯-1,2-二羧酸盐的合成与晶体结构
Acta Crystallogr E Crystallogr Commun. 2022 Aug 26;78(Pt 9):947-952. doi: 10.1107/S2056989022008337. eCollection 2022 Sep 1.
9
Six 1-halobenzoyl-4-(2-meth-oxy-phen-yl)piperazines having ' values of one, two or four; disorder, pseudosymmetry, twinning and supra-molecular assembly in one, two or three dimensions.六个具有一、二或四个‘值’的1-卤代苯甲酰基-4-(2-甲氧基苯基)哌嗪;一维、二维或三维的无序、假对称、孪晶和超分子组装。
Acta Crystallogr E Crystallogr Commun. 2021 Jan 1;77(Pt 1):5-13. doi: 10.1107/S2056989020015649.
10
Co-crystallization of 3,5-di-nitro-benzoic acid with two anti-psychotic agents: a simple 1:1 salt with trihexyphenidyl and a 1:2 acid salt containing a very short O-H⋯O hydrogen bond with chlorprothixene.3,5-二硝基苯甲酸与两种抗精神病药物的共结晶:与苯海索形成简单的1:1盐,与氯普噻吨形成含极短O-H⋯O氢键的1:2酸盐。
Acta Crystallogr E Crystallogr Commun. 2019 Jan 31;75(Pt 2):292-298. doi: 10.1107/S2056989019001385. eCollection 2019 Feb 1.

引用本文的文献

1
Syntheses, crystal structures and Hirshfeld surface analysis of three salts of 1-(4-nitro-phenyl)-piperazine.1-(4-硝基苯基)哌嗪三种盐的合成、晶体结构及 Hirshfeld 表面分析
Acta Crystallogr E Crystallogr Commun. 2023 Mar 21;79(Pt 4):373-379. doi: 10.1107/S2056989023002517. eCollection 2023 Mar 1.
2
1-(3,5-Di-nitro-benzo-yl)-4-(2-meth-oxy-phen-yl)piper-azine.1-(3,5-二硝基苯甲酰基)-4-(2-甲氧基苯基)哌嗪
IUCrdata. 2020 Nov 20;5(Pt 11):x201523. doi: 10.1107/S2414314620015230. eCollection 2020 Nov.
3
The structures of eleven (4-phen-yl)piperazinium salts containing organic anions.

本文引用的文献

1
Order disorder in two isomorphous pyrazolone-substituted diethyl propane-dioates prepared using a three-component one-pot reaction under solvent-free conditions.在无溶剂条件下通过三组分一锅法反应制备的两种同构吡唑啉酮取代二乙基丙二酸酯中的有序-无序现象
Acta Crystallogr E Crystallogr Commun. 2020 Sep 8;76(Pt 10):1605-1610. doi: 10.1107/S2056989020011676. eCollection 2020 Oct 1.
2
The crystal structures of salts of -(4-fluoro-phen-yl)piperazine with four aromatic carb-oxy-lic acids and with picric acid.-(4-氟苯基)哌嗪与四种芳香羧酸及苦味酸形成的盐的晶体结构
Acta Crystallogr E Crystallogr Commun. 2020 Jul 3;76(Pt 8):1179-1186. doi: 10.1107/S2056989020008749. eCollection 2020 Aug 1.
3
十一种含有机阴离子的(4-苯基)哌嗪鎓盐的结构
Acta Crystallogr E Crystallogr Commun. 2022 Sep 22;78(Pt 10):1016-1027. doi: 10.1107/S2056989022009057. eCollection 2022 Oct 1.
4
Syntheses and crystal structures of 4-(4-meth-oxy-phen-yl)piperazin-1-ium 4-methyl-benzoate monohydrate and bis-[4-(4-meth-oxy-phen-yl)piperazin-1-ium] benzene-1,2-di-carboxyl-ate.4-(4-甲氧基苯基)哌嗪-1-鎓 4-甲基苯甲酸盐一水合物和双-[4-(4-甲氧基苯基)哌嗪-1-鎓]苯-1,2-二羧酸盐的合成与晶体结构
Acta Crystallogr E Crystallogr Commun. 2022 Aug 26;78(Pt 9):947-952. doi: 10.1107/S2056989022008337. eCollection 2022 Sep 1.
5
Crystal structure of 4-(2-meth-oxy-phen-yl)piper-azin-1-ium 3,5-dintrosalicylate.4-(2-甲氧基苯基)哌嗪-1-鎓 3,5-二硝基水杨酸盐的晶体结构
Acta Crystallogr E Crystallogr Commun. 2022 Jul 12;78(Pt 8):774-778. doi: 10.1107/S2056989022006831. eCollection 2022 Aug 1.
6
Crystal-structure studies of 4-phenyl-piperazin-1-ium 4-eth-oxy-benzoate monohydrate, 4-phenyl-piperazin-1-ium 4-meth-oxy-benzoate monohydrate, 4-phenyl-piperazin-1-ium 4-methyl-benzoate monohydrate and 4-phenyl-piperazin-1-ium tri-fluoro-acetate 0.12-hydrate.4-苯哌嗪-1-鎓4-乙氧基苯甲酸酯一水合物、4-苯哌嗪-1-鎓4-甲氧基苯甲酸酯一水合物、4-苯哌嗪-1-鎓4-甲基苯甲酸酯一水合物及4-苯哌嗪-1-鎓三氟乙酸酯0.12水合物的晶体结构研究
Acta Crystallogr E Crystallogr Commun. 2022 Jun 10;78(Pt 7):709-715. doi: 10.1107/S2056989022006004. eCollection 2022 Jul 1.
7
Crystal structures of six 4-(4-nitro-phenyl)-piperazin-1-ium salts.六种4-(4-硝基苯基)哌嗪-1-鎓盐的晶体结构
Acta Crystallogr E Crystallogr Commun. 2022 Apr 26;78(Pt 5):510-518. doi: 10.1107/S2056989022004157. eCollection 2022 May 1.
8
Crystal structure studies of 4-ethyl-piperazin-1-ium 3,5-di-nitro-benzoate, 4-methyl-piperazin-1-ium 3,5-di-nitro-benzoate and 4-methyl-piperazin-1-ium 4-iodo-benzoate.4-乙基哌嗪-1-鎓 3,5-二硝基苯甲酸盐、4-甲基哌嗪-1-鎓 3,5-二硝基苯甲酸盐和 4-甲基哌嗪-1-鎓 4-碘苯甲酸盐的晶体结构研究
Acta Crystallogr E Crystallogr Commun. 2021 Oct 21;77(Pt 11):1135-1139. doi: 10.1107/S2056989021010689. eCollection 2021 Nov 1.
9
Construction of Two Stable Co(II)-Based Hydrogen-Bonded Organic Frameworks as a Luminescent Probe for Recognition of Fe and CrO in HO.构建两个稳定的 Co(II)-基氢键有机框架作为 HO 中 Fe 和 CrO 识别的荧光探针。
Molecules. 2021 Sep 30;26(19):5955. doi: 10.3390/molecules26195955.
10
Six 1-halobenzoyl-4-(2-meth-oxy-phen-yl)piperazines having ' values of one, two or four; disorder, pseudosymmetry, twinning and supra-molecular assembly in one, two or three dimensions.六个具有一、二或四个‘值’的1-卤代苯甲酰基-4-(2-甲氧基苯基)哌嗪;一维、二维或三维的无序、假对称、孪晶和超分子组装。
Acta Crystallogr E Crystallogr Commun. 2021 Jan 1;77(Pt 1):5-13. doi: 10.1107/S2056989020015649.
Three 4-(4-fluoro-phen-yl)piperazin-1-ium salts containing organic anions: supra-molecular assembly in one, two and three dimensions.
三种含有有机阴离子的4-(4-氟苯基)哌嗪-1-鎓盐:一维、二维和三维超分子组装体
Acta Crystallogr E Crystallogr Commun. 2020 May 15;76(Pt 6):841-847. doi: 10.1107/S2056989020006398. eCollection 2020 Jun 1.
4
Crystal structures of the recreational drug -(4-meth-oxy-phen-yl)piperazine (MeOPP) and three of its salts.消遣性药物1-(4-甲氧基苯基)哌嗪(MeOPP)及其三种盐的晶体结构。
Acta Crystallogr E Crystallogr Commun. 2020 Mar 5;76(Pt 4):488-495. doi: 10.1107/S2056989020002844. eCollection 2020 Apr 1.
5
validation ALERTS: what they mean and how to respond.验证警报:其含义及应对方法
Acta Crystallogr E Crystallogr Commun. 2020 Jan 1;76(Pt 1):1-11. doi: 10.1107/S2056989019016244.
6
Twelve 4-(4-meth-oxy-phen-yl)piperazin-1-ium salts containing organic anions: supra-molecular assembly in one, two and three dimensions.十二种含有机阴离子的4-(4-甲氧基苯基)哌嗪-1-鎓盐:一维、二维和三维超分子组装
Acta Crystallogr E Crystallogr Commun. 2019 Sep 20;75(Pt 10):1494-1506. doi: 10.1107/S2056989019012702. eCollection 2019 Oct 1.
7
Six 1-aroyl-4-(4-meth-oxy-phen-yl)piperazines: similar mol-ecular structures but different patterns of supra-molecular assembly.六种1-芳酰基-4-(4-甲氧基苯基)哌嗪:相似的分子结构但超分子组装模式不同。
Acta Crystallogr E Crystallogr Commun. 2019 Jul 26;75(Pt 8):1253-1260. doi: 10.1107/S2056989019010491. eCollection 2019 Aug 1.
8
Synthesis and evaluation of antidepressant-like activity of some 4-substituted 1-(2-methoxyphenyl)piperazine derivatives.某些4-取代的1-(2-甲氧基苯基)哌嗪衍生物的合成及其抗抑郁样活性评价
Chem Biol Drug Des. 2015 Mar;85(3):326-35. doi: 10.1111/cbdd.12394. Epub 2014 Aug 14.
9
Use of intensity quotients and differences in absolute structure refinement.强度商数的使用及绝对结构精修中的差异
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2013 Jun;69(Pt 3):249-59. doi: 10.1107/S2052519213010014. Epub 2013 May 17.
10
2-Amino-6-methoxy-4-(4-methylanilino)-5-nitrosopyrimidine and ethyl N-[4-(adamantan-1-ylamino)-2-amino-5-nitrosopyrimidin-6-yl]-3-aminopropionate: polarized electronic structures and hydrogen-bonded supramolecular assembly in one and two dimensions.2-氨基-6-甲氧基-4-(4-甲基苯胺基)-5-亚硝基嘧啶和N-[4-(金刚烷-1-基氨基)-2-氨基-5-亚硝基嘧啶-6-基]-3-氨基丙酸乙酯:一维和二维中的极化电子结构和氢键超分子组装
Acta Crystallogr C. 2012 May;68(Pt 5):o199-203. doi: 10.1107/S0108270112017921. Epub 2012 Apr 26.